Selah Therapeutics
Juvenescence and the Buck Institute launch Selah Therapeutics, targeting heart disease
Juvenescence & the Buck Institute announce a new joint venture with the formation of Selah Therapeutics Limited (“Selah”). Selah focuses on developing ketone-based therapies to treat heart fail...
Juvenescence Ltd. Portfolio Company Hails Successful Limb Regeneration in Adult Frogs
Morphoceuticals Inc., a portfolio company of Juvenescence Ltd., hailed the results of a long-term study published by its founders in Science Advances showing the successful regeneration of limbs in...